Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Nidan Laboratories IPO is a fixed price issue of ₹50.00 crores. The issue is entirely a fresh issue of 0.40 crore shares of ₹50.00 crore.
Nidan Laboratories IPO bidding started from Oct 28, 2021 and ended on Nov 2, 2021. The allotment for Nidan Laboratories IPO was finalized on Nov 9, 2021. The shares got listed on NSE SME on Nov 12, 2021.
Nidan Laboratories IPO price is ₹125.00 per share . The lot size for an application is 1,000. The minimum amount of investment required by an individual investor (retail) is ₹1,25,000 (1000 shares). The minimum lot size investment for HNI is 2 lots (2,000 shares), amounting to ₹2,50,000.
First Overseas Capital Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The market maker of the company is NNM Securities Pvt.Ltd..
Refer to Nidan Laboratories IPO RHP for detailed Information.
| IPO Date | October 28, 2021 to November 2, 2021 |
| Listing Date | November 12, 2021 |
| Face Value | ₹10 per share |
| Issue Price Band | |
| Issue Price Final | ₹125 per share |
| Lot Size | 1,000 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 40,00,000 shares (aggregating up to ₹50.00 Cr) |
| Reserved for Market Maker | 2,00,000 shares NNM Securities Pvt.Ltd. (aggregating up to ₹2.50 Cr) |
| Net Offered to Public | 38,00,000 shares (aggregating up to ₹47.50 Cr) |
| Issue Type | Fixed Price IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 99,00,000 shares |
| Share Holding Post Issue | 1,39,00,000 shares |
Nidan Laboratories and Healthcare IPO offers total 40,00,000 shares. Out of which 19,00,000 (47.50%) allocated to NII, 19,00,000 (47.50%) allocated to RII.
| Investor Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 2,00,000 (5.00%) |
| NII (HNI) Shares Offered | 19,00,000 (47.50%) |
| Retail Shares Offered | 19,00,000 (47.50%) |
| Total Shares Offered | 40,00,000 (100.00%) |
Nidan Laboratories IPO opens on October 28, 2021, and closes on November 2, 2021.
| IPO Open Date | Thu, Oct 28, 2021 |
| IPO Close Date | Tue, Nov 2, 2021 |
| Tentative Allotment | Tue, Nov 9, 2021 |
| Initiation of Refunds | Wed, Nov 10, 2021 |
| Credit of Shares to Demat | Thu, Nov 11, 2021 |
| Tentative Listing Date | Fri, Nov 12, 2021 |
| Cut-off time for UPI mandate confirmation | 5 PM on Tue, Nov 2, 2021 |
Investors can bid for a minimum of 1,000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,000 | ₹1,25,000 |
| Retail (Max) | 1 | 1,000 | ₹1,25,000 |
| HNI (Min) | 2 | 2,000 | ₹2,50,000 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in the year 2000, Nidan Laboratories and Healthcare Limited offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. As of March 31, 2021, the company offered approximately 740 routine and 3000 specialized pathology tests and approximately 220 basic and 320 advanced radiology tests that cover a range of specialties and disciplines. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to advanced radiology tests including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans. The company also offers a broad spectrum of customized health and wellness packages to its customers and offers value-added services to its customers such as a home collection of specimens, house calls, and various delivery or access modes for test reports.
Nidan has come out with a unique appointment booking mobile application under the name of "NIDAN HEALTHCARE" which is supported by self-indigenous software called "Nidan Operation Management (NOM)." This unique app enables patients to book appointments for any test, from anywhere, at any time. The company has also tied up with pathology partners like Metropolis Laboratories Limited for its services.
Out of the 35 centers operating under the brand name of "Nidan Healthcare", 16 centers are under the Franchisee model where 1 center acts as a fully operated diagnostic center and 15 centers act solely as standalone collection centers. As of June 30, 2021, the company had a total of 213 employees. The company has got recognitions like the Best Diagnostic Chain of India Award 2019, in the Category of 20+ diagnostic centers by Express Healthcare.
Competitive Strengths:
| Particulars | For the year/period ended (₹ in Millions) | ||||
|---|---|---|---|---|---|
| 30-Jun-21 | 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | ||
| Total Assets | 543.30 | 524.36 | 452.07 | 430.57 | |
| Total Revenue | 78.45 | 218.53 | 221.91 | 209.72 | |
| Profit After Tax | 10.87 | 23.02 | 7.14 | 2.23 | |
The net proceed from the IPO will be utilized towards the following purposes;
[Dilip Davda] For the last three fiscals, Nidan Laboratories top line remained static, but profit margins improved with a sharp rise for FY21. It has expressed similar trends for FY22 Q1, but the sustainability of such margins going forward is a major concern as the segment is highly fragmented and witnessing a cutthroat competition. Due to pandemics, these segments gained fancy and perhaps this company is trying to encase on this boom. Based on financial parameters the asking price is high. Hence there is no harm in ignoring this issue. Read detail review...
| Listing Date | November 12, 2021 |
| BSE Script Code | |
| NSE Symbol | NIDAN |
| ISIN | INE0J6L01013 |
| Final Issue Price | ₹125 per share |
| BSE Listing Group | ST |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹125.00 |
| Open | ₹123.90 |
| Low | ₹117.75 |
| High | ₹123.90 |
| Last Trade | ₹117.75 |
Nidan Laboratories & Healthcare Ltd.
Swapnshilpa, Behind Aarti Apartment,
Vartak Road,
Palagar,
Mumbai, Maharashtra, 401303
Phone: +91 8975610000
Email: cs@nidanhealthcare.co.in
Website: https://nidanhealthcare.co.in/
Bigshare Services Pvt.Ltd.
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html
Nidan Laboratories IPO is a SME IPO of 40,00,000 equity shares of the face value of ₹10 aggregating up to ₹50.00 Crores. The issue is priced at ₹125 per share. The minimum order quantity is 1000.
The IPO opens on October 28, 2021, and closes on November 2, 2021.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Nidan Laboratories IPO using UPI as a payment gateway. Zerodha customers can apply in Nidan Laboratories IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Nidan Laboratories IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Nidan Laboratories IPO opens on October 28, 2021 and closes on November 2, 2021.
Nidan Laboratories IPO lot size is 1000, and the minimum amount required for application is ₹1,25,000.
You can apply in Nidan Laboratories IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Nidan Laboratories IPO will be done on Tuesday, November 9, 2021, and the allotted shares will be credited to your demat account by Thursday, November 11, 2021. Check the Nidan Laboratories IPO allotment status.
The Nidan Laboratories IPO listing date is on Friday, November 12, 2021.
Useful Articles
RHP